Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Jianguo Zhou's research, publications, and ongoing work
Developed a liquid biopsy method for early-stage hepatocellular carcinoma detection in asymptomatic patients, published in PNAS.
Identified Icaritin as a novel anti-cancer agent that inhibits hepatocellular carcinoma initiation and growth by targeting the IL-6/Jak2/Stat3 pathway.
Demonstrated the role of RIPK1 in mediating mitochondrial Ca2+ uptake, promoting colorectal oncogenesis.
Contributed to the development of expert statements on systemic therapy for hepatocellular carcinoma.
Identified preoperative D-dimer and Gamma-Glutamyltranspeptidase as predictors of complications and survival in patients with colorectal liver metastases.
Identified ARID2 as a new tumor suppressor gene in hepatocellular carcinoma.
Analyzed the impact of postoperative infectious complications on long-term outcomes for patients undergoing simultaneous resection for colorectal cancer liver metastases.
Dr. Jianguo Zhou is a leading researcher in hepatocellular carcinoma and colorectal cancer, with significant contributions to early detection methods and novel therapeutic approaches. His work focuses on improving patient outcomes through innovative research in oncology and related fields.
Researchers with overlapping expertise and complementary work
Finding similar researchers...